Cindy Tahl - Jan 3, 2022 Form 4 Insider Report for FATE THERAPEUTICS INC (FATE)

Role
General Counsel and Secretary
Signature
/s/ Cindy Tahl
Stock symbol
FATE
Transactions as of
Jan 3, 2022
Transactions value $
-$2,639,353
Form type
4
Date filed
1/4/2022, 03:03 PM
Previous filing
Nov 22, 2021
Next filing
Jan 12, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FATE Common Stock Options Exercise $328K +50K +29.58% $6.55 219K Jan 3, 2022 Direct F1
transaction FATE Common Stock Sale -$256K -4.43K -2.02% $57.76* 215K Jan 3, 2022 Direct F1, F2
transaction FATE Common Stock Sale -$994K -16.9K -7.88% $58.84* 198K Jan 3, 2022 Direct F1, F3
transaction FATE Common Stock Sale -$1.66M -27.8K -14.07% $59.86* 170K Jan 3, 2022 Direct F1, F4
transaction FATE Common Stock Sale -$51.9K -861 -0.51% $60.31* 169K Jan 3, 2022 Direct F1, F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FATE Stock Option (Right to Buy) Options Exercise $0 -50K -42.87% $0.00 66.6K Jan 3, 2022 Common Stock 50K $6.55 Direct F1, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 8, 2021.
F2 Represents the weighted average sale price of the shares sold ranging from $57.26 to $58.18 to per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price within the ranges set forth in footnotes 2 through 5.
F3 Represents the weighted average sale price of the shares sold ranging from $58.26 to $59.25 per share.
F4 Represents the weighted average sale price of the shares sold ranging from $59.30 to $60.29 per share.
F5 Represents the weighted average sale price of the shares sold ranging from $60.30 to $60.33 per share.
F6 This option is fully vested.